Form 4 for CCCC C4 Therapeutics, Inc.
Accepted 2022-07-05 00:00:00 ET · period of report 2022-07-01 · accession 0001209191-22-040597 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-05 | 2022-07-01 | CCCC | Anderson Kenneth Carl | Dir | A - Grant | $8.03 | +1,246 | 89.6K | +1% | +$10.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-01 | A | A | 1,246 | $8.03 | 89,562 | D | — | — | (F2) The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 1, 2022. |